Allergan SWOT and PESTLE Analysis
COMPANY PROFILE -Allergan
Business Sector :Pharmaceutical Industry
Operating Geography :Ireland, Europe, Global
About Allergan :
Allergan plc, is headquartered in Dublin, Ireland. It is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan focuses on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. The company markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.Allergan Revenue :
14570.6 million USD (2016)Competitive Analysis of Allergan
1. A sound R&D strategy 2. TEVA agreement 3. Operations in more than 100 countries with sound business strategy | 1. High dependency on suppliers 2. High dependency on regulatory laws in foreign countries as well as in the US 3. Dependency on small number of large wholesalers and distributors as primary customers |
1. Integrating recently acquired businesses to enhance profitability 2. Improving control over suppliers as well customers 3. Timely development and launches of new products ahead of competitors | 1. Large competitors with deep pockets 2. Company can be subjected to various litigations 3. After market developments |
Complete Report
USD 11.72
- Debit/Credit card
- PayPal
Detailed SWOT Analysis of Allergan
Opportunities
1. Integrating recently acquired businesses to enhance profitability: Recently in 2016 Allergan has acquired Tobira Therapeutics Inc., Vitae Pharmaceuticals Inc., ForSight VISION Inc. The companies if integrated properly regarding culture, alignment of vision, business practices could result into hefty profits for Allergan as the acquisitions are done keeping in mind the business strategy of acquiring the companies which are complementing the business of the company.
2. Improving control over suppliers as well customers: The company currently is not holding a position of power in front of their suppliers as well as buyers because, in both suppliers and buyers case, small number of big players are controlling the markets. The company’s expansion in new international markets brings them the opportunity to find new potential suppliers as well as the buyers which can help the company acquire greater power during negotiations.
3. Timely development and launches of new products ahead of competitors: Pharmaceutical Industry is a highly competitive industry, and a first mover advantage can prove to be immensely beneficial to company’s revenue. Robust R&D strategy provides the company an opportunity to develop and launch new products ahead of competitors. Effective marketing of the product and the brand symbolizing technological innovations will improve the sales of the company’s products.
The unpublished sections of the entire SWOT analysis is available in the 'Complete Report' on purchase.
Complete Report
USD 11.72
- Debit/Credit card
- PayPal
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Allergan:
-
Allergan Porter's Five Forces Analysis -
Allergan VRIO Analysis -
Allergan Value Chain Analysis -
Allergan Covid-19 Impact Analysis -
Allergan BCG Analysis -
Allergan Segmentation, Targeting and Positioning (STP) Analysis -
Allergan Ansoff Matrix Analysis
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Allergan SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2024). Allergan SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/allergan/ [Accessed 05 Nov, 2024].
In-text: (SWOT & PESTLE.com, 2024)
Copyrights and Disclaimer
Allergan SWOT and PESTLE analysis has been conducted by Parth Joshi and reviewed by senior analysts from Barakaat Consulting.
Copyright of Allergan SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.